Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12

被引:374
|
作者
Huse, M
Chen, YG
Massagué, J
Kuriyan, J
机构
[1] Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA
关键词
D O I
10.1016/S0092-8674(00)80555-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the type I TGF beta receptor (T beta R-I) requires phosphorylation of a regulatory segment known as the GS region, located upstream of the serine/threonine kinase domain in the cytoplasmic portion of the receptor, The crystal structure of a fragment of unphosphorylated T beta R-I, containing both the GS region and the catalytic domain, has been determined in complex with the FK506-binding protein FKBP12. T beta R-I adopts an inactive conformation that is maintained by the unphosphorylated GS region, FKBP12 binds to the GS region of the receptor, capping the T beta R-II phosphorylation sites and further stabilizing the inactive conformation of T beta R-I. Certain structural features at the catalytic center of T beta R-I are characteristic of tyrosine kinases rather than Ser/Thr kinases.
引用
收藏
页码:425 / 436
页数:12
相关论文
共 50 条
  • [21] FKBP12 modulates gating of the ryanodine receptor calcium release channel
    Ondrias, K
    Marx, SO
    Gaburjakova, M
    Marks, AR
    CARDIAC SARCOPLASMIC RETICULUM FUNCTION AND REGULATION OF CONTRACTILITY, 1998, 853 : 149 - 156
  • [22] Ryanodine Receptor Phosphorylation by Protein Kinase a Alters the Affinity for FKBP12
    Griffiths, Julia
    Jones, Jonathan-Lee
    Lai, F. Anthony
    Blayney, Lynda
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 108A - 108A
  • [23] X-ray crystal structure of 28-O-methylrapamycin complexed with FKBP12: Is the cyclohexyl moiety part of the effector domain of rapamycin?
    Kallen, JA
    Sedrani, R
    Cottens, S
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (25) : 5857 - 5861
  • [24] Insertion of a chaperone domain converts FKBP12 into a powerful catalyst of protein folding
    Knappe, Thomas A.
    Eckert, Barbara
    Schaarschmidt, Peter
    Scholz, Christian
    Schmid, Franz X.
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 368 (05) : 1458 - 1468
  • [25] NOVEL MODULATORS OF SKELETAL-MUSCLE FKBP12 CALCIUM-CHANNEL COMPLEX FROM IANTHELLA-BASTA - ROLE OF FKBP12 IN CHANNEL GATING
    MACK, MM
    MOLINSKI, TF
    BUCK, ED
    PESSAH, IN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (37) : 23236 - 23249
  • [26] THE AFFINITY OF THE EXCISED BINDING DOMAIN OF FK-506 FOR THE IMMUNOPHILIN FKBP12
    TEAGUE, SJ
    STOCKS, MJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (10) : 1947 - 1950
  • [27] Chaperone-like activity of immunophilin FKBP12 from bovine brain, a cytoplasmic receptor of immunosuppressor FK506
    E. M. Lyutova
    A. S. Kasakov
    B. Ya. Gurvits
    Neurochemical Journal, 2007, 1 : 196 - 203
  • [28] Chaperone-like activity of immunophilin FKBP12 from bovine brain, a cytoplasmic receptor of immunosuppressor FK506
    Lyutova, E. M.
    Kasakov, A. S.
    Gurvits, B. Ya.
    NEUROCHEMICAL JOURNAL, 2007, 1 (03) : 196 - 203
  • [29] FKBP12 is not required for the modulation of transforming growth factor β receptor I signaling activity in embryonic fibroblasts and thymocytes
    Bassing, CH
    Shou, WN
    Muir, S
    Heitman, J
    Matzuk, MM
    Wang, XF
    CELL GROWTH & DIFFERENTIATION, 1998, 9 (03): : 223 - 228
  • [30] Dilated cardiopathy after suppression of FKBP12, a modifier of ryanodin receptor function
    Charlemagne, C
    M S-MEDECINE SCIENCES, 1998, 14 (6-7): : 799 - 801